HRMY Past Earnings image   This HRMY past earnings page last updated 11/3/2022
HRMY Past Earnings
PeriodPast Earnings DateAdj. EPS
Q3 202211/1/20220.950
Q2 20228/2/20220.570
Q1 20225/3/20220.510
Q4 20212/28/20220.630
Q3 202111/9/20210.510
Q2 20218/10/20210.540
Q1 20215/11/20210.380
Q4 20203/25/20210.250
Q3 202011/12/2020-0.140
HRMY Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/1/20220.12B
Q2 20228/2/20220.11B
Q1 20225/3/20220.09B
Q4 20212/28/20220.09B
Q3 202111/9/20210.08B
Q2 20218/10/20210.07B
Q1 20215/11/20210.06B
Q4 20203/25/20210.06B
Q3 202011/12/20200.05B
Quotes delayed 20 minutes

Email EnvelopeFree HRMY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Harmony Biosciences (HRMY) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

HROW Past Earnings
HRTX Past Earnings
HSDT Past Earnings
HSIC Past Earnings
HSKA Past Earnings
HSTO Past Earnings
HTBX Past Earnings
HTGM Past Earnings
HUMA Past Earnings
HZNP Past Earnings

HRMY Past Earnings Q&A

What was the best and worst HRMY past earnings results?
For Harmony Biosciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest HRMY past earnings result in our data set was 0.950/share posted in Q3 2022, while the lowest was in Q3 2020 when HRMY posted -0.140/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2022 when HRMY reported 0.12B in revenue, while the quarter with the lowest revenue in our data set was Q3 2020 at 0.05B of revenue.

  Suggested answer: There are 9 HRMY past earnings results in our data set.

On this page we presented the HRMY past earnings date information for Harmony Biosciences. Reviewing that HRMY Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2022, when HRMY posted adjusted EPS of 0.950/share. Meanwhile the lowest HRMY past earnings result was in Q3 2020, when HRMY posted adjusted EPS of -0.140/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2022 when HRMY reported 0.12B in revenue, while the smallest revenue quarter was Q3 2020 when HRMY reported 0.05B in revenue.

Any self directed investor doing their due diligence on HRMY or any other given stock can benefit from researching all of the Harmony Biosciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Harmony Biosciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for HRMY. Thanks for visiting, and the next time you need to research HRMY past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: MRGR YTD Return, Top Ten Hedge Funds Holding ULH, Top Ten Hedge Funds Holding BOCN.

 

HRMY Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.